The productivity incentives of TEFRA are compared, using a sample that includes ten patients, four on Medicare and the remainder being either private pay patients or patients covered by commercial insurance. The effect of a ten percent increase or decrease in productivity on Medicare reimbursement before and after TEFRA is examined.